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Abstract
Background: Type I interferons (IFN) are a heterogeneous group of cytokines central to innate and adaptive
antiviral immune responses. We have recently reported that porcine type I IFNs comprise at least 39 functional
genes with diverse antiviral activity against porcine reproductive and respiratory syndrome virus (PRRSV). Here we
report that potential cytokine polymorphisms exist in several genes of porcine type I IFNs.
Results: We have detected more than 100 potential polymorphic mutations, which include nucleotide
substitutions and deletions, within the coding regions of porcine type I IFNs. Approximately 50% of the nucleotide
changes were mutations that resulted in non-conserved amino acid substitution, as well as deletions that
produced frame shifts in the open reading frames (ORFs). We have identified more than 20 polymorphic mutants
that showed alterations in anti-PRRSV and anti-vesicular stomatitis virus (VSV) activity in vitro. In particular, some
mutations in IFN-a2, IFN-a3, IFN-a8, IFN-a12 and IFN-ω5 significantly altered the antiviral activity of expressed
proteins in comparison to the wild-type or variant with more similarity to the wild-type.
Conclusions: Multiple polymorphic isoforms potentially exist within subtypes of the porcine type I IFN family.
Polymorphic mutations are more common in multiple-member subtypes than single-member subtypes, and most
are found within the IFN-a subclass. Some polymorphic isoforms have altered amino acid composition and shifted
ORFs, which show significantly different antiviral activity in vitro.
Background
Type I interferons (IFNs) are a family of cytokines pro-
minent in antiviral responses [1,2]. Genetic mutations
that result in dysfunction of type I IFN production and
actions are ultimately associated with susceptibility to
viral diseases [2,3]. Conversely, viruses may antagonize
or evade type I IFN actions resulting in successful infec-
tions [4]. In this context, porcine reproductive and
respiratory syndrome virus (PRRSV), a RNA virus that
causes devastating losses in the global swine industry,
suppresses type I IFN production [5,6]; and diverse
PRRSV strains manifest different abilities to suppress
type I IFN expression [7]. Furthermore, emerging evi-
dence implicates that cytokine polymorphisms such as
those in IFN-g and interleukin (IL)-8 are key factors in
breed- or genotype-associated viral resistance [8-10].
However, how type I IFN polymorphisms affect resis-
tance to PRRSV infection is not known. We have
recently reported that the porcine type I IFN family
consists of at least 39 functional genes, which are classi-
fied into seven subclasses of 17 IFN-a, 11 IFN-δ, and 7
IFN-ω subtypes, and single-subtype subclasses consisting
of IFN-aω, IFN-b, IFN-ε, and IFN- [11]. We showed
that members of different or the same porcine type I
IFN subclasses have diverse expression profiles in var-
ious pig tissues and in vitro antiviral activities [11]. Here
we report that expressed proteins from multiple poly-
morphic isoforms within subtypes of type I IFNs have
significantly altered antiviral activity, which may repre-
sent an important factor for determining the outcome
of the host-virus interaction.
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Methods
The isolation and analyses of IFN genes were conducted
as previously described [11]. In brief, coding regions of
porcine IFNs were amplified from several cDNA and
genomic DNA pools using a high-fidelity PCR with sub-
type-common cloning primers. PCR fragments, which
flank six nucleotides before the start codon and stop
codon of each IFN ORF, were purified and cloned into
a pcDNA™ 3.3-TOPO® TA cloning/expression vector
(Invitrogen, Carlsbad, CA) under the action of the vec-
tor CVM promoter. At least five clones for each IFN
gene were sequenced and clones that showed the high-
est sequence identity (>97%) to the reference sequences
(extracted from genomic draft sequences by Sanger
Institute Porcine Project Team, which is available from
http://www.ensembl.org/Sus_scrofa/index.html) were
selected as polymorphic variants of a particular IFN for
mutation definition and protein expression. Mutation
determination was conducted by combined use of
sequence analysis tools in Lasergene v8.1 (DNASTAR,
Inc. Madison, WI) and Bioedit (http://www.mbio.ncsu.
edu/BioEdit/bioedit.html). IFN peptides were collected
and partially purified from supernatants of HEK293F
cells transfected with individual IFN-expression plas-
mids. Authentic expression of individual IFN peptides
was confirmed by gel electrophoresis; and peptide
concentrations were adjusted to 2 μg/ml with the
serum-free medium to ensure the antiviral differences
were not a result of peptide levels in the antiviral assays
(11). Antiviral activity of overexpressed IFN peptides
was assayed as the inhibition of the cytopathic effect
(CPE) of PRRSV and VSV on MARC-145 and PK-15
cells, respectively, in which 1 unit is defined as the high-
est dilution that reduced cell loss by 50% according to
the Reed-Muench method [11].
Results and conclusions
Existence of multiple polymorphic isoforms in IFN-a, IFN-
δ and IFN-ω subtypes
Summarized in Table 1 are 18 polymorphic isoforms
that have non-conservative amino acid changes and
potentially show altered antiviral activity. Indeed, single
nucleotide polymorphisms (SNP) have been found in
most porcine IFN subtypes, in particular in IFN-a, IFN-
ω and IFN-δ subclasses, which consist of multiple sub-
types. Among all SNPs, approximately 50% cause
changes at the amino acid level, including non-conserva-
tive substitution of certain residues and deletions result-
ing in frame shift of translation. The SNP sites are
detected along all regions including signal peptides and
the five helical regions but are concentrated within the
middle region of 40-150 amino acid residues.
Table 1 Polymorphic isoforms of porcine type I interferons (IFNs)
IFN polymorphic isoforms Different from reference sequences1
NA ® AA
Potential responsible mutations2
IFNa2-1 7 SNP 5 AA L40-F, C109-R
IFNa2-2 5 SNP 3 AA A127-V
IFNa3-1 5 SNP 4 AA K145-E,
IFNa3-2 7 SNP 6 AA L40-F
IFNa6-1 (Wild type)
IFNa6-2 4 SNP 1 AA D101-N
IFNa8-1 8 SNP 5 AA N17-D
IFNa8-2 7 SNP 4 AA
IFNa8μ 8 SNP 2 AA T9-M, d(R46)
IFNa10-1 12 SNP 8 AA F88-S
IFNa10-2 12 SNP 8 AA K73-E
IFNa12-1 3 SNP S158-N, P161-L
IFNa12-2 4 SNP 1 AA L90-P, D101-N, A127-V, V174-A
IFNa12μ 10 SNP (ORF) ORF shifted after 100 AA
IFNδ1-1 1 SNP 1 AA T65-A
IFNδ1-2 2 SNP 1 AA N91-T
IFNω5-1 3 SNP 1 AA C52-R
IFNω5-2 1 SNP
IFNω5μ 6 SNP (ORF) d(stop) and added C-17 AA
1.Reference sequences were extracted from genomic draft sequences by Sanger Institute Porcine Project Team at the Wellcome Trust Sanger Institute and can be
obtained from http://www.ensembl.org/Sus_scrofa/index.html. NA, Nucleic acid; AA, amino acid; SNP, single nucleotide polymorphism; (ORF), shifted open
reading frame. 2. Potential responsible mutations are defined as mutations at the protein levels in the predicted mature peptide region and those occurring only
in the isoforms with altered antiviral activity. Amino acid residues are shown as single letter symbols, L40-F indicating the 40th leucine mutated to phenylalanine,
for example. d(X) or d(stop), deletion of indicated residue X or stop codon.
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Diverse activity of polymorphic type I IFNs
Using IFN polypeptides expressed in a mammalian cell
system [11], eight polymorphic IFNs showed altered anti-
viral activity against both PRRSV and VSV in vitro consid-
ering the different effects of cytopathic inhibition with the
same amount of peptides. In comparison to the wild-type
or the variant with more similarity to the wild-type, resi-
dual substitution of Leu40-Phe and Cys109-Arg in IFN-a2-
1, Lys145-Glu in IFN-a3-1, deletion of Arg46 in IFN-a8μ,
Phe88-Ser in IFN-a10-1, and Cys52-Arg in IFN-ω5-1, dra-
matically reduced antiviral activity against both PRRSV
and VSV. The mutations had a more profound effect on
reducing anti-PRRSV activity in MARC-145 cells than
anti-VSV activity in PK-15 cells (Fig. 1). In addition, dele-
tion mutants, such as IFN-a8μ and IFN-a12μ which are
more atypical in their peptide sequence, showed little anti-
viral activity in both virus-cell systems. Because poly-
morphism among porcine type I IFN genes may represent
an important factor for determining the outcome of the
host-virus interaction, it will be informative to correlate
IFN polymorphism in pigs with susceptibility to PRRSV
and severity of PRRSV infection.
Acknowledgements
This work was supported in part by USDA NRICGP grants 2003-35204-13704
and 2006-35204-17337. We thank Danielle Goodband for her excellent
technical support.
This article has been published as part of BMC Proceedings Volume 5
Supplement 4, 2011: Proceedings of the International Symposium on Animal
Genomics for Animal Health (AGAH 2010). The full contents of the
supplement are available online at http://www.biomedcentral.com/1753-
6561/5?issue=S4.
Author details
1Department of Anatomy and Physiology, College of Veterinary Medicine,
Kansas State University, Manhattan, Kansas, USA. 2Department of Diagnostic
Medicine and Pathobiology, College of Veterinary Medicine, Kansas State
University, Manhattan, Kansas, USA.
Competing interests
The authors declare no competing interests related to this manuscript.
Published: 3 June 2011
References
1. Le Bon A, Tough DF: Type I interferon as a stimulus for cross-priming.
Cytokine Growth Factor Rev. 2008, 19:33-40.
2. Kohlmeier JE, Woodland DL: Immunity to respiratory viruses. Annu Rev
Immunol. 2009, 27:61-82.
3. Pichlmair A, Reis e Sousa C: Innate recognition of viruses. Immunity 2007,
27:370-383.
4. Weber F, Haller O: Viral suppression of the interferon system. Biochimie.
2007, 89:836-842.
5. Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ,
Seitzinger AH, Green AL, Zimmerman JJ: Assessment of the economic
impact of porcine reproductive and respiratory syndrome on swine
production in the United States. J Am Vet Med Assoc. 2005,
227:385-392.
6. Beura LK, Sarkar SN, Kwon B, Subramaniam S, Jones C, Pattnaik AK,
Osorio FA: Porcine reproductive and respiratory syndrome virus
nonstructural protein 1beta modulates host innate immune response by
antagonizing IRF3 activation. J Virol. 2010, 84:1574-1584.
PRRSV vs MARC-145
ac
tiv
ity
 (1
05
 U
/n
g/
m
l) VSV vs PK-15
0.8
1.0
2.0
3.0
4.0
5.0
* *
*
*
* * *
*
*
*
* *
*
*
] ]
] ]
]
]
]
]
]
]
]
]
IFN
An
tiv
ira
l a
IFN
0.0
0.4
Į2
-1
Į2
-2
Į3
-1
Į3
-2
Į6
-1
Į6
-2
Į8
-1
Į8
-2
Į8
ȝ
Į1
0
-1
Į1
0
-2
Į1
2
-1
Į1
2
-2
Į1
2
ȝ
Ȧ
5
ȝ
Ȧ
5
-2
Ȧ
5
-1
Į2
-1
Į2
-2
Į3
-1
Į3
-2
Į6
-1
Į6
-2
Į8
-1
Į8
-2
Į8
ȝ
Į1
0
-1
Į1
0
-2
Į1
2
-1
Į1
2
-2
Į1
2
ȝ
Ȧ
5
ȝ
Ȧ
5
-2
Ȧ
5
-1
Figure 1 Differential antiviral activity among polymorphic isoforms of some subtypes of porcine type I IFNs. Antiviral activity against
PRRSV and VSV was evaluated as described in Sang et al., 2010 [11], and analyzed based on individual polymorphic isoforms. Authentic
expression of individual IFN peptides was confirmed by gel electrophoresis. Peptide concentrations were adjusted to 2 μg/ml to ensure the
antiviral differences were not a result of peptide levels in the antiviral assays. Antiviral activity of overexpressed IFN peptides was assayed as the
inhibition of virus cytopathic effect, in which 1 unit (U) is defined as the highest dilution that reduced cell loss by 50% according to the Reed-
Muench method. Data are means from four duplicates of two independent experiments. *p<0.05, n=4.
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